[HTML][HTML] Potential pathogenesis of ageusia and anosmia in COVID‐19 patients
LA Vaira, G Salzano, AG Fois, P Piombino… - International forum of …, 2020 - ncbi.nlm.nih.gov
The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in
Europe and America is enabling researchers to acquire a large amount of clinical data. …
Europe and America is enabling researchers to acquire a large amount of clinical data. …
[HTML][HTML] Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF), the most common form of idiopathic interstitial pneumonia,
is a progressive, irreversible, and typically lethal disease characterized by an abnormal …
is a progressive, irreversible, and typically lethal disease characterized by an abnormal …
[HTML][HTML] Molecular epidemiology of the main druggable genetic alterations in non-small cell lung cancer
SS Fois, P Paliogiannis, A Zinellu, AG Fois… - International journal of …, 2021 - mdpi.com
Lung cancer is the leading cause of death for malignancy worldwide. Its molecular profiling
has enriched our understanding of cancer initiation and progression and has become …
has enriched our understanding of cancer initiation and progression and has become …
Objective evaluation of anosmia and ageusia in COVID‐19 patients: single‐center experience on 72 cases
LA Vaira, G Deiana, AG Fois, P Pirina… - Head & …, 2020 - Wiley Online Library
Background The first European case series are detecting a very high frequency of chemosensitive
disorders in COVID‐19 patients, ranging between 19.4% and 88%. Methods Olfactory …
disorders in COVID‐19 patients, ranging between 19.4% and 88%. Methods Olfactory …
[HTML][HTML] The systemic inflammation index on admission predicts in-hospital mortality in COVID-19 patients
AG Fois, P Paliogiannis, V Scano, S Cau, S Babudieri… - Molecules, 2020 - mdpi.com
Background. The rapid onset of a systemic pro-inflammatory state followed by acute
respiratory distress syndrome is the leading cause of mortality in patients with COVID-19. We …
respiratory distress syndrome is the leading cause of mortality in patients with COVID-19. We …
Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010
…, L Cazzoletti, I Cerveri, AG Fois… - European …, 2012 - Eur Respiratory Soc
The prevalence of asthma increased worldwide until the 1990s, but since then there has
been no clear temporal pattern. The present study aimed to assess time trends in the …
been no clear temporal pattern. The present study aimed to assess time trends in the …
Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives
P Paliogiannis, AG Fois, S Sotgia… - European …, 2018 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised
by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a …
by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a …
[HTML][HTML] Cholesterol and triglyceride concentrations, COVID-19 severity, and mortality: a systematic review and meta-analysis with meta-regression
Lipid profile alterations have been observed in patients with coronavirus disease 2019 (COVID-19)
in relation to disease severity and mortality. We conducted a systematic review and …
in relation to disease severity and mortality. We conducted a systematic review and …
[HTML][HTML] Circulating biomarkers of oxidative stress in chronic obstructive pulmonary disease: a systematic review
Chronic obstructive pulmonary disease (COPD) is a progressive condition characterized by
airflow limitation associated with an abnormal inflammatory response of the lungs to noxious …
airflow limitation associated with an abnormal inflammatory response of the lungs to noxious …
Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era?
G Madeddu, AG Fois, GM Calia, S Babudieri, V Soddu… - Infection, 2013 - Springer
Purpose The objective of our study was to evaluate the presence of respiratory symptoms
and chronic obstructive pulmonary disease (COPD) in a human immunodeficiency virus (HIV)-…
and chronic obstructive pulmonary disease (COPD) in a human immunodeficiency virus (HIV)-…